{
  "id": 17350247,
  "title": "Corona Remedies Reports Robust Q2 FY27, Revenue Up 22.2% To ₹441.2 Crore; Chronic Business Drives Growth",
  "url": "https://urgent.news/2026/10/31/corona-remedies-reports-robust-q2-fy27-revenue-up-22-2-to-441-2-crore",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-31T05:17:37.000Z",
  "source": {
    "name": "Free Press Journal",
    "slug": "free-press-journal",
    "url": "https://www.freepressjournal.in/business/corona-remedies-reports-robust-q2-fy27-revenue-up-222-to-4412-crore-chronic-business-drives-growth"
  },
  "original_language": "en",
  "account": null,
  "summary": "Mumbai: Corona Remedies Limited on October 30, 2026, announced its unaudited financial results for the quarter and half year ended September 30, 2026, reporting significant growth in revenue and profit. Financial Performance The company's revenue from operations increased to ₹441.2 crore in Q2 FY27 from ₹361.1 crore in Q2 FY26. Earnings before interest, tax, depreciation, and amortisation…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}